| Literature DB >> 36209217 |
Zhigui Ma1, Yan Zhu1, Yining Zhan1, Yufan Zhang1, Ahmed Abdelrehem2, Bian Wang3, Chi Yang4.
Abstract
BACKGROUND: Periodontal accelerated osteogenic orthodontics (PAOO) is a widely-used clinical procedure that combines selective alveolar corticotomy, particulate bone grafting, and the application of orthodontic forces. Different modifications of PAOO such as collagen-membrane coverage can better benefit patients from preventing displacement of grafts. Due to its stability, collagen-membrane coverage gradually gained popularity and became a widely-used procedure in traditional PAOO technique.Entities:
Keywords: Alveolar bone defect; Bone regenerative surgery; Collagen membrane; Periosteum; Vertical bone augmentation
Mesh:
Substances:
Year: 2022 PMID: 36209217 PMCID: PMC9548201 DOI: 10.1186/s12903-022-02477-8
Source DB: PubMed Journal: BMC Oral Health ISSN: 1472-6831 Impact factor: 3.747
Fig. 1Schematic diagram of the periosteum-covered periodontally accelerated osteogenic orthodontics (PAOO) surgery. A Periosteum dissection, corticotomy, paired holes and grafting performed in the lower anterior region; B the periosteum was sutured to the alveolus through the holes and acted as an encapsulating membrane to cover the graft materials in a dumpling-like fashion
Fig. 2Surgical procedure. A–D PAOO with periosteum coverage; E–H PAOO with a resorbable membrane coverage
Fig. 3A Illustration of radiographic assessments; B CBCT images of the lower left canine for two groups at 3 different time points (red arrow indicates corticotomy); C 3D reconstruction and surface distances on color-coded maps of the lower anterior region measured preoperatively and 12 months after PAOO in the test and The comparator groups
Fig. 4CONSORT flow diagram
Baseline data of test and control group (intention to treat analysis)
| Test group | Control group | Between groups ( | |
|---|---|---|---|
| Age mean† | 20.78 ± 2.24 | 21.06 ± 2.92 | NS |
| Male | 2(11.1) | 4(22.2) | NS |
| Female | 16(88.9) | 14(77.8) | NS |
| I | 2(11.1) | 2(11.1) | NS |
| II | 9(50) | 11(61.1) | NS |
| III | 7(38.9) | 5(27.8) | NS |
| Dehiscences, sites (%)‡ | 14(77.8) | 12(66.7) | NS |
| Fenestrations, sites (%)‡ | 6(33.3) | 4(22.2) | NS‡ |
†Mann–Whitney test
‡Chi-square test
The operative time and post-operative complications of test and control groups (per protocol analysis)
| Test group, n = 16 | Control group, n = 16 | Between groups ( | |
|---|---|---|---|
| Time† | 61.19 ± 4.53 | 33.87 ± 4.66 | < 0.001 |
| 2d | 4.63 ± 1.02 | 5.31 ± 1.2 | 0.160 |
| 7d | 2.56 ± 0.89 | 3.34 ± 1.25 | 0.061 |
| Within groups( | < 0.001 | < 0.001 | |
| 2d | 10.62 ± 4.8 | 9.94 ± 4.81 | 0.752 |
| 7d | 4.87 ± 4.29 | 5.00 ± 6.27 | 0.381 |
| Within groups( | 0.004 | 0.005 | |
| Infection (%)§ | 2(12.5) | 0(0) | 0.484 |
| Numbness of the lip (%)§ | 1(6.25) | 2(12.5) | 1.000 |
†Mann–Whitney test
‡Wilcoxon signed-rank test
§Chi-square test
Radiographic parameters of test and control groups over time (intention to treat analysis for the lower left canine)
| T0 | T1 | T2 | Within groups ( | |
|---|---|---|---|---|
| Test group, n = 18 | 6.21 ± 1.54 | 2.13 ± 2.45 | 2.52 ± 2.23 | < 0.001 |
| Control group, n = 18 | 6.06 ± 2.91 | 1.36 ± 1.92 | 4.17 ± 2.6 | < 0.001 |
| Between groups( | 0.963 | 0.279 | 0.027 | |
| Test group, n = 18 | 0.13 ± 0.25 | 3.31 ± 1.58 | 1.95 ± 1.12 | < 0.001 |
| Control group, n = 18 | 0.17 ± 0.43 | 3.14 ± 1.79 | 2.18 ± 1.25 | < 0.001 |
| Between groups( | 0.696 | 0.650 | 0.462 | |
| Test group, n = 18 | 1.64 ± 0.57 | 4.29 ± 1.80 | 3.16 ± 2.18 | < 0.001 |
| Control group, n = 18 | 1.92 ± 0.97 | 4.05 ± 1.62 | 3.64 ± 2.22 | < 0.001 |
| Between groups ( | 0.864 | 0.650 | 0.501 | |
T0 at baseline; T1 postoperative 1 week; T2 postoperative 12 months
†Friedman’s test
‡Mann–Whitney test
Periodontal parameters of test and control groups over time (mm) (intention to treat analysis for the lower left canine)
| T0 | T2 | Within groups ( | |
|---|---|---|---|
| Test group, n = 18 | 1.02 ± 0.50 | 1.02 ± 0.33 | 0.979 |
| Control group, n = 18 | 1.05 ± 0.40 | 1.02 ± 0.55 | 0.815 |
| Between groups( | 0.815 | 0.938 | |
| Test group, n = 18 | 0.69 ± 0.85 | 0.53 ± 0.68 | 0.176 |
| Control group, n = 18 | 0.81 ± 1.22 | 0.42 ± 0.42 | 0.777 |
| Between groups( | 0.308 | > 0.999 | |
| Test group, n = 18 | 2.57 ± 0.47 | 2.94 ± 1.04 | 0.213 |
| Control group, n = 18 | 2.86 ± 1.41 | 2.94 ± 1.36 | 0.274 |
| Between groups ( | 0.888 | 0.913 | |
T0 at baseline; T2 postoperative 12 months
†Wilcoxon signed-rank test
‡Mann–Whitney test